Cellectar Biosciences, Inc.
CLRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001279704
No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.08M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Cellectar Biosciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −11 vs. Q2 2022
- Shares held
- 636.5K
- −28.9K (−4.3%) vs. Q2 2022Converted for a 1-for-10 split
- Total value
- $2.14M
- −$1.47M (−40.7%) vs. Q2 2022
- New holders
- 2
- 5 more added
- Sold out
- 13
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $9.08M |
| Q1 2026 | 19 | $812.9K |
| Q4 2025 | 20 | $1.04M |
| Q3 2025 | 21 | $1.65M |
| Q2 2025 | 19 | $734.0K |
| Q1 2025 | 32 | $1.63M |
| Q4 2024 | 30 | $1.52M |
| Q3 2024 | 35 | $30.0M |
| Q2 2024 | 37 | $28.3M |
| Q1 2024 | 45 | $36.3M |
| Q4 2023 | 26 | $23.9M |
| Q3 2023 | 20 | $3.85M |
| Q2 2023 | 21 | $3.08M |
| Q1 2023 | 21 | $2.43M |
| Q4 2022 | 26 | $3.22M |
| Q3 2022 | 22 | $2.14M |
| Q2 2022 | 33 | $3.61M |
| Q1 2022 | 32 | $4.69M |
| Q4 2021 | 42 | $4.38M |
| Q3 2021 | 40 | $6.77M |
| Q2 2021 | 46 | $14.9M |
| Q1 2021 | 45 | $24.2M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Cellectar Biosciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 175,377 | $589.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| AIGH Capital Management LLC | 174,422 | $586.0K | 0.23% | −9,283−5.1% | ReducedConverted for a 1-for-10 split |
| BlackRock Inc. | 57,042 | $192.0K | 0.00% | −403−0.7% | ReducedConverted for a 1-for-10 split |
| Geode Capital Management, LLC | 44,439 | $149.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Worth Venture Partners, LLC | 41,636 | $140.0K | 0.09% | −4,189−9.1% | ReducedConverted for a 1-for-10 split |
| Maven Securities LTD | 25,000 | $84.0K | 0.00% | −15,000−37.5% | ReducedConverted for a 1-for-10 split |
| ACT Capital Management, LLC | 21,750 | $73.0K | 0.10% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Renaissance Technologies LLC | 17,690 | $59.0K | 0.00% | +1,040+6.2% | AddedConverted for a 1-for-10 split |
| State Street Corp | 15,714 | $53.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Morgan Stanley | 15,001 | $50.0K | 0.00% | +14,999+789,426.3% | AddedConverted for a 1-for-10 split |
| Bank of New York Mellon Corp | 12,109 | $41.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Monticello Wealth Management, LLC | 12,000 | $40.0K | 0.00% | +12,000 | New |
| Franklin Resources Inc | 10,364 | $35.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Difesa Capital Management, LP | 10,000 | $34.0K | 0.02% | +9,000+900.0% | AddedConverted for a 1-for-10 split |
| UBS Group AG | 1,650 | $6.00K | 0.00% | −2,314−58.4% | ReducedConverted for a 1-for-10 split |
| Tower Research Capital LLC (TRC) | 1,486 | $5.00K | 0.00% | −166−10.0% | ReducedConverted for a 1-for-10 split |
| Advisor Group Holdings, Inc. | 521 | $2.00K | 0.00% | +21+4.2% | AddedConverted for a 1-for-10 split |
| US Bancorp | 285 | $1.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| IFP Advisors, Inc | 5 | $1.00K | 0.00% | +5+900.0% | AddedConverted for a 1-for-10 split |
| Wells Fargo & Company | 39 | $0 | 0.00% | −1−1.3% | ReducedConverted for a 1-for-10 split |
| AllSquare Wealth Management LLC | 18 | $0 | 0.00% | −1−4.3% | ReducedConverted for a 1-for-10 split |
| Benjamin Edwards Inc | 1 | $0 | 0.00% | +1 | New |
| Northern Trust Corp | 0 | $0 | 0.00% | −9,544−100.0% | Sold outConverted for a 1-for-10 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −6,899−100.0% | Sold outConverted for a 1-for-10 split |
| Cozad Asset Management Inc | 0 | $0 | 0.00% | −5,600−100.0% | Sold outConverted for a 1-for-10 split |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −3,680−100.0% | Sold outConverted for a 1-for-10 split |
| Modera Wealth Management, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold outConverted for a 1-for-10 split |
| Commerce Bank | 0 | $0 | 0.00% | −1,428−100.0% | Sold outConverted for a 1-for-10 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −1,544−100.0% | Sold outConverted for a 1-for-10 split |
| Scotia Capital Inc. | 0 | $0 | 0.00% | −1,136−100.0% | Sold outConverted for a 1-for-10 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −1,354−100.0% | Sold outConverted for a 1-for-10 split |
| Johnson Financial Group, Inc. | 0 | $0 | 0.00% | −550−100.0% | Sold outConverted for a 1-for-10 split |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −525−100.0% | Sold outConverted for a 1-for-10 split |
| Bank of America Corp | 0 | $0 | 0.00% | −150−100.0% | Sold outConverted for a 1-for-10 split |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −200−100.0% | Sold outConverted for a 1-for-10 split |